Transgenomic announces issuance of new COLD-PCR technologies patent Transgenomic announced that the European Patent Office has issued a new patent, European Patent No. 21833798, covering one of its COLD-PCR family of DNA amplification technologies. The patent covers Full COLD-PCR. The COLD-PCR technology is owned by the Dana-Farber Cancer Institute, Boston USA, and exclusively licensed to Transgenomic. The new European patent helps extend the scope and longevity of the COLD-PCR intellectual property portfolio, which was originally developed by the laboratory of Mike Makrigiorgos at the Dana-Farber Cancer Institute. Transgenomic is also pursuing additional European patent coverage specific to ICE COLD-PCR technology.